Bordetella pertussis pertactin antigen (formaldehyde inactivated)

DB10992ApprovedInvestigationalVaccinesInactivated Bordetella Pertussis Vaccine

Bordetella pertussis pertactin antigen (formaldehyde inactivated): Overview.

First approval
United States, 2008
Brand names
  • Boostrix
  • Infanrix
  • Kinrix
  • Pediarix

Resolves to

Compound
UNIII05O535NV6

What you can answer from here — as of April 02, 2025

130Clinical trialsPhase, status and sponsor resolved per trial
Sign in
18Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
46Marketed productsAcross 5 countries and 7 labellers
Sign in

Which other approved drugs treat the same conditions as Bordetella pertussis pertactin antigen (formaldehyde inactivated), and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In